Identification and measurement of kynurenic acid in the rat brain and other organs
✍ Scribed by V. Carlá; G. Lombardi; M. Beni; P. Russi; G. Moneti; F. Moroni
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 417 KB
- Volume
- 169
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
✦ Synopsis
Kynurenic acid, a biologically active tryptophan metabolite, has been identified and measured in the rat brain and other organs using HPLC and GC/MS. Both the described methods required extraction of the compound in alkaline ethanol and initial purification on Dowex ion-exchange resins. The GC/MS approach used 3-hydroxy-2-naphthoic acid as an internal standard and a derivatization procedure with diazomethane and trifluoroacetic anhydride. The HPLC procedure was performed on a reverse-phase column using a spectrophotometric detector. Both the GC/MS and the HPLC methods had the lowest detection limit in the range of 10 pmol/injection, but the variability of the results was lower when HPLC was used. HPLC analysis showed the content of kynurenic acid to be 14 +/- 2 pmol/g wet wt in the brain, 75 +/- 7 in the heart, 87 +/- 8 in the liver, and 298 +/- 10 in the kidneys. Comparable but variable values were obtained with GC/MS.
📜 SIMILAR VOLUMES
## Abstract Kynurenic acid (KYNA), one of the tryptophan metabolites, serves as an endogenous antagonist of __N__‐methyl‐d‐aspartate and the __α__7 nicotinic receptors in mammalian brains. In the present study, the column‐switching high‐performance liquid chromatography (HPLC) method we developed f
A sensitive and specific analytical method has been developed for the measurement of beta-phenylethylamine (PEA) in human plasma and rat brain extracts. The method involves solvent extraction of PEA with cyclohexane in the presence of amphetamine or phenylpropylamine (PPA) as internal standards. Aut